2005
DOI: 10.1007/bf03016554
|View full text |Cite
|
Sign up to set email alerts
|

Syringe pump displacement alters line internal pressure and flow

Abstract: Vertical displacement of the syringe pump alters the flow due to a change of line IP, and blood pressure can be affected by pump movement during NE infusion.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
7
0

Year Published

2007
2007
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 14 publications
(7 citation statements)
references
References 12 publications
0
7
0
Order By: Relevance
“…The actual clinical effect of vertical displacement was shown by Igarashi et al . in a rabbit model. A 50‐cm downward displacement of the pump with a preprogrammed flow rate of 1 ml·h −1 resulted in an internal pressure (IP) increase of 37.4 ± 2.6 mmHg (5.0 ±0.3 kPa).…”
Section: Resultsmentioning
confidence: 98%
“…The actual clinical effect of vertical displacement was shown by Igarashi et al . in a rabbit model. A 50‐cm downward displacement of the pump with a preprogrammed flow rate of 1 ml·h −1 resulted in an internal pressure (IP) increase of 37.4 ± 2.6 mmHg (5.0 ±0.3 kPa).…”
Section: Resultsmentioning
confidence: 98%
“…The combination of these high concentrations, small delivery volumes, and the requirement for infusion interruption for syringe changes may result in the potential inconsistent rate of delivery and may result in significant haemodynamic effects. [1][2][3] It has long been observed by critical care providers that haemodynamically unstable patients experience potentially hazardous changes in vital signs related to the exchange of depleted syringes to full, fresh vasoactive medication syringes.…”
Section: Ntravenous Vasoactive Drugs Are Administeredmentioning
confidence: 99%
“…The simulation system was assembled with the following devices: two different types of syringe pump (Pilot A2 ® ; Fresenius Kabi AG, Bad Homburg, Germany; Injectomat Agilia ® , Fresenius Kabi AG), a 50-mL syringe (BD Perfusion 50 mL Syringe; Becton Dickinson, Franklin Lakes, NJ, USA), a 250-cm-long infusion tubing (ICU Medical, San Clemente, CA, USA), three-way stopcock (Bicakcilar, Istanbul, Turkey), hemodynamic pressure transducer (TruWave; Edwards Lifesciences, Irvine CA, USA), multiparametric monitor (Draeger SC 9000; Draeger Medical, Telford, Pennsylvania, USA), two different types of neutral displacement NFC (Neutraclear ® ; Becton Dickinson, Bionecteur ® ; Vygon, Ecouen, France) with different performances, 10,11 and 500 mL of colored normal saline connected to an Infusion Set (Rays SpA, Osimo, Italy). Variables studied were the following: type of pump used, pump highness in relation to the simulated patient, 12,13 three different CVP simulated values, 8,9 connection between the syringe and the infusion tubing, and operator. The pump positions considered in relation to the patient were 50 cm above the position of the heart, patient in supine position (heart level) and 32 cm below the patient, with respect to heart level.…”
Section: Study Design and Settingmentioning
confidence: 99%